Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer women of multiple ethnic region in northwest China

Journal of Breast Cancer

Volumn 16, Issue 1, 2013, Pages 50-54

  Ou, Jianghua ^a   Wu, Tao ^a   Sijmons, Rolf ^b   Ni, Duo ^a   Xu, Wenting ^a   Upur, Halmurat ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

BRCA1; BRCA2; Breast neoplasms; Chinese; Ethnic groups; Genetic variation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; BREAST CANCER; CHINA; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE INTERACTION; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MUTATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; TRIPLE NEGATIVE BREAST CANCER;

EID: 84876096691     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.1.50     Document Type: Article

References (30)

1. The National Bureau of Statistics of China, Department of Population, Social, Science and Technology Statistics; The State Ethnic Affairs Commission of China, Department of Economic Development. Tabulation on Nationalities of 2000 Population Census of China. Beijing: Nationalities Publishing House; 2003.
2. Kwong A, Wong LP, Wong HN, Law FB, Ng EK, Tang YH, et al. Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 2009;3:63-76.
3. Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, et al. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese wom en with familial breast cancer. Breast Cancer Res Treat 2012;132:421-8.
4. Cao AY, Hu Z, Shao ZM. Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Cancer Res Treat 2010;120:271-2.
5. Arnold N, Gross E, Schwarz-Boeger U, Pfisterer J, Jonat W, Kiechle M. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat 1999;14:333-9.
6. Breast Cancer Information Core. National Human Genome Research Institute. http://research.nhgri.nih.gov/bic/Member/index.shtml. Accessed February 26th, 2013.
7. Newman B, Austin MA, Lee M, King MC. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A 1988;85:3044-8.
8. Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 1989;45:521-9.
9. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
10. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993;52:678-701.
11. Nurwidya F, Takahashi F, Takahashi K. Meeting report: current cancer perspectives from the 9th Annual Meeting of the Japanese Society of Medical Oncology. Thorac Cancer 2012;3:94-7.
12. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 2000;83:1301-8.
13. Sng JH, Chang J, Feroze F, Rahman N, Tan W, Lim S, et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 2000;82:538-42.
14. Li SS, Tseng HM, Yang TP, Liu CH, Teng SJ, Huang HW, et al. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 1999;104:201-4.
15. Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, et al. The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 2006;132:617-26.
16. Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH. Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country. World J Surg 2009;33:2077-81.
17. Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, et al. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 2008;10:R59.
18. Ang P, Lim IH, Lee TC, Luo JT, Ong DC, Tan PH, et al. BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev 2007;16:2276-84.
19. Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, et al. Estrogen receptor status in BRCA1-and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004;10:2029-34.
20. Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 1998;83:2335-45.
21. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 2004;22:1638-45.
22. Juwle A, Saranath D. BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. Med Oncol 2012;29:3272-81.
23. Han SH, Lee KR, Lee DG, Kim BY, Lee KE, Chung WS. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 2006;70:496-501.
24. Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM, et al. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Hum Mutat 2004;24:350.
25. Ahn SH, Hwang UK, Kwak BS, Yoon HS, Ku BK, Kang HJ, et al. Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci 2004;19:269-74.
26. Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, et al. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 2000;83:737-42.
27. Manguoǧlu E, Güran S, Yamaç D, Colak T, Simşek M, Baykara M, et al. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Cancer Genet Cytogenet 2010;203:230-7.
28. Liang Y, Fu D, Hu G. Metadherin: an emerging key regulator of the malignant progression of multiple cancers. Thorac Cancer 2011;2:143-8.
29. Chen WQ, Zheng RS, Zeng HM, Zhang SW, Li GL, Wu LY, et al. Incidence and mortality of breast cancer in China, 2008. Thorac Cancer. Epub 2012 Jul 11. DOI: http://dx.doi.org/10.1111/j.1759-7714.2012.00165.x.
30. Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, Domínguez-Muñoz JE. Endoscopic ultrasound elastography. Endosc Ultrasound 2012;1:8-16.